Equities

Rion Co Ltd

Rion Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,476.00
  • Today's Change-2.00 / -0.08%
  • Shares traded11.30k
  • 1 Year change+12.65%
  • Beta1.7217
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Rion Co Ltd grew revenues 7.79% from 23.87bn to 25.73bn while net income improved 47.39% from 1.80bn to 2.65bn.
Gross margin50.40%
Net profit margin9.72%
Operating margin12.58%
Return on assets7.03%
Return on equity8.98%
Return on investment8.17%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Rion Co Ltd fell by 346.35m. However, the company earned 2.86bn from its operations for a Cash Flow Margin of 11.11%. In addition the company used 2.65bn on investing activities and also paid 565.55m in financing cash flows.
Cash flow per share298.10
Price/Cash flow per share8.33
Book value per share2,443.26
Tangible book value per share2,247.82
More ▼

Balance sheet in JPYView more

Rion Co Ltd uses little or no debt in its capital structure.
Current ratio3.87
Quick ratio2.41
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 11.11% and 47.28%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.80%
Div growth rate (5 year)4.56%
Payout ratio (TTM)15.20%
EPS growth(5 years)5.73
EPS (TTM) vs
TTM 1 year ago
5.61
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.